Cargando…
Cardiac risk stratification in cancer patients: A longitudinal patient–patient network analysis
BACKGROUND: Cardiovascular disease is a leading cause of death in general population and the second leading cause of mortality and morbidity in cancer survivors after recurrent malignancy in the United States. The growing awareness of cancer therapy–related cardiac dysfunction (CTRCD) has led to an...
Autores principales: | Hou, Yuan, Zhou, Yadi, Hussain, Muzna, Budd, G. Thomas, Tang, Wai Hong Wilson, Abraham, James, Xu, Bo, Shah, Chirag, Moudgil, Rohit, Popovic, Zoran, Watson, Chris, Cho, Leslie, Chung, Mina, Kanj, Mohamed, Kapadia, Samir, Griffin, Brian, Svensson, Lars, Collier, Patrick, Cheng, Feixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366997/ https://www.ncbi.nlm.nih.gov/pubmed/34339408 http://dx.doi.org/10.1371/journal.pmed.1003736 |
Ejemplares similares
-
Machine Learning–Based Risk Assessment for Cancer Therapy–Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients
por: Zhou, Yadi, et al.
Publicado: (2020) -
Impact of timing of atrial fibrillation, CHA(2)DS(2)-VASc score and cancer therapeutics on mortality in oncology patients
por: Hussain, Muzna, et al.
Publicado: (2020) -
Cardiovascular Complications in Major 21(st) Century Viral Epidemics and Pandemics: an Insight into COVID-19
por: Hussain, Muzna, et al.
Publicado: (2021) -
Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological Mechanisms
por: Rikhi, Rishi, et al.
Publicado: (2021)